Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Total Non-Current Liabilities (2022 - 2025)

Q32 Bio (QTTB) has 4 years of Total Non-Current Liabilities data on record, last reported at $19.8 million in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 37.57% year-over-year to $19.8 million; the TTM value through Dec 2025 reached $19.8 million, down 37.57%, while the annual FY2025 figure was $19.8 million, 37.57% down from the prior year.
  • Total Non-Current Liabilities reached $19.8 million in Q4 2025 per QTTB's latest filing, down from $21.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $48.5 million in Q1 2024 and bottomed at $19.8 million in Q4 2025.
  • Average Total Non-Current Liabilities over 4 years is $32.0 million, with a median of $31.5 million recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: rose 13.57% in 2023, then crashed 42.04% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $37.7 million in 2022, then rose by 13.57% to $42.8 million in 2023, then fell by 26.1% to $31.7 million in 2024, then tumbled by 37.57% to $19.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $19.8 million in Q4 2025, $21.2 million in Q3 2025, and $23.4 million in Q2 2025.